Thrombin stimulates RPE cell motility by PKC-ζ- and NF-κB-dependent gene expression of MCP-1 and CINC-1/GRO chemokines

Journal of Cellular Biochemistry

Volumn 110, Issue 4, 2010, Pages 948-967

  Palma Nicolás, José Prisco ^a   López, Edith ^a   López Colomé, Ana María ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

GRO; MCP 1; PAR 1; RPE; Thrombin

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ZETA; THROMBIN; CXCL1 CHEMOKINE; CXCL1 PROTEIN, RAT; PRIMER DNA; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; NEWBORN; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENETICS; LONG EVANS RAT; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WOUND HEALING;

RATTUS;

ANIMALS; BASE SEQUENCE; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINE CXCL1; DNA PRIMERS; GENE EXPRESSION; NF-KAPPA B; PROTEIN KINASE C; RATS; RATS, LONG-EVANS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBIN; UP-REGULATION; WOUND HEALING;

EID: 77954100130     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22608     Document Type: Article

References (50)

1. Abu El-Asrar AM, Struyf S, Descamps FJ, Al-Obeidan SA, Proost P, Van Damme J, Opdenakker G, Geboes K. 2004. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol 138:401-411.
2. Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J. 2006. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 17:155-165.
3. Allen SJ, Crown SE, Handel TM. 2007. Chemokine: Receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787-820.
4. Anisowicz A, Messineo M, Lee SW, Sager R. 1991. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol 147:520-527.
5. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. 2001. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22:147-184.
6. Banisadr G, Skrzydelski D, Kitabgi P, Rostene W, Parsadaniantz SM. 2003. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: Constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 18:1593-1606.
7. Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G, Dorcaratto A, Ravetti JL, Minuto F, Spaziante R, Schettini G, Ferone D, Florio T. 2008. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 14:5022-5032.
8. Barnes PJ, Karin M. 1997. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
9. Bian ZM, Elner SG, Yoshida A, Elner VM. 2004. Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci 45:1887-1896.
10. Campochiaro PA. 1997. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 115:237-241.
11. Cao H, Dronadula N, Rao GN. 2006. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells. Am J Physiol Cell Physiol 290:C172-C182.
12. Capeans C, De Rojas MV, Lojo S, Salorio MS. 1998. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina 18:546-550. (Pubitemid 30387560)
13. Conrath J. 2007. Risk factors for recurrent retinal detachment. J Fr Ophtalmol 30:847-851.
14. Coughlin SR. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258-264.
15. Crane IJ, Kuppner MC, McKillop-Smith S, Knott RM, Forrester JV. 1998. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol 184:37-44.
16. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. 2000a. CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol 165:4372-4378.
17. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. 2000b. CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol 165:4372-4378.
18. Crook RB, Song MK, Tong LP, Yabu JM, Polansky JR, Lui GM. 1992. Stimulation of inositol phosphate formation in cultured human retinal pigment epithelium. Brain Res 583:23-30.
19. Duarte M, Kolev V, Soldi R, Kirov A, Graziani I, Oliveira SM, Kacer D, Friesel R, Maciag T, Prudovsky I. 2006. Thrombin induces rapid PAR1-mediated non-classical FGF1 release. Biochem Biophys Res Commun 350:604-609.
20. Duran A, Diaz-Meco MT, Moscat J. 2003. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22:3910-3918.
21. Elner VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. 1990. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 136:745-750.
22. Elner SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL. 1991. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 64:819-825.
23. Elner SG, Delmonte D, Bian ZM, Lukacs NW, Elner VM. 2006. Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8. Exp Eye Res 83:374-379.
24. Harada C, Harada T, Mitamura Y, Quah HM, Ohtsuka K, Kotake S, Ohno S, Wada K, Takeuchi S, Tanaka K. 2004. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Mol Vis 10:31-36.
25. Hayden MS, West AP, Ghosh S. 2006. NF-kappaB and the immune response. Oncogene 25:6758-6780.
26. Hollborn M, Petto C, Steffen A, Trettner S, Bendig A, Wiedemann P, Bringmann A, Kohen L. 2009. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors. Invest Ophthalmol Vis Sci 50:4452-4459.
27. Jordan NJ, Watson ML, Yoshimura T, Westwick J. 1996. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br J Pharmacol 117:1245-1253. (Pubitemid 26105349)
28. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663.
29. Karin M, Lin A. 2002. NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227.
30. Karp JM, Tanaka TS, Zohar R, Sodek J, Shoichet MS, Davies JE, Stanford WL. 2005. Thrombin mediated migration of osteogenic cells. Bone 37:337-348.
31. Kaufmann R, Rahn S, Pollrich K, Hertel J, Dittmar Y, Hommann M, Henklein P, Biskup C, Westermann M, Hollenberg MD, Settmacher U. 2007. Thrombin-mediated hepatocellular carcinoma cell migration: Cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol 211:699-707.
32. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, Camacho F, Diaz-Meco MT, Rennert PD, Moscat J. 2001. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell 8:771-780.
33. Li S, Guan JL, Chien S. 2005. Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng 7:105-150.
34. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. 2001. Proteinase-activated receptors. Pharmacol Rev 53:245-282.
35. McLaughlin JN, Patterson MM, Malik AB. 2007. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104:5662-5667.
36. Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED, White FA, Zhang J. 2008. Chemokine action in the nervous system. J Neurosci 28:11792-11795.
37. Moscat J, Diaz-Meco MT, Wooten MW. 2009. Of the atypical PKCs, Par-4 and p62: Recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death Differ 16:1426-1437.
38. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK. 2008. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42-48.
39. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, Brass LF. 2000. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275:13502-13509.
40. Palma-Nicolas JP, Lopez E, Lopez-Colome AM. 2008. PKC isoenzymes differentially modulate thrombin effect on MAPK-dependent RPE proliferation. Biosci Rep. 28:307-317.
41. Parrales A, Palma-Nicolas JP, Lopez E, Lopez-Colome AM. 2010. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression. J Cell Physiol 222:302-312.
42. Ramachandran R, Hollenberg MD. 2008. Proteinases and signalling: Pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153(Suppl 1):S263-S282.
43. Rehak M, Hollborn M, Iandiev I, Pannicke T, Karl A, Wurm A, Kohen L, Reichenbach A, Wiedemann P, Bringmann A. 2009. Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci 50:2359-2367.
44. Uchida D, Onoue T, Tomizuka Y, Begum NM, Miwa Y, Yoshida H, Sato M. 2007. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res 5:685-694.
45. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. 1997. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 272:31092-31099.
46. Viola A, Luster AD. 2008. Chemokines and their receptors: Drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 48:171-197. (Pubitemid 351756361)
47. Wang B, Hendricks DT, Wamunyokoli F, Parker MI. 2006. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 66:3071-3077.
48. Wang Y, Luo W, Reiser G. 2007. Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. Biochem J 401:65-78.
49. Yang Z, Cohen RL, Lui GM, Lawrence DA, Shuman MA. 1995. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor. Invest Ophthalmol Vis Sci 36:2254-2261.
50. Yoshida A, Elner SG, Bian ZM, Kunkel SL, Lukacs NW, Elner VM. 2001. Thrombin regulates chemokine induction during human retinal pigment epithelial cell/monocyte interaction. Am J Pathol 159:1171-1180.